Obatoclax Mesylate and Topotecan Hydrochloride in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer or Advanced Solid Tumors

Clinical trial NCT00521144 · COMPLETED

Trial details

NCT number: NCT00521144
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Recurrent Small Cell Lung Cancer Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2007-08-01
Primary completion: 2010-08-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.